conor douglas retweeted
The Government of Canada announces investments of up to $1.5B over three years to increase access to, and affordability of, effective drugs for rare diseases.
ow.ly/Hcx6104zIZ0
conor douglas retweeted
On Rare Disease Day SPIN Team Leader @cmwDouglas will present work entitled "Disrupting dominant bio-pharma industrial approaches to rare disease treatment through 'social pharmaceutical innovation' (SPIN)", as a part of the STS Departmental Seminar Series at York University.
conor douglas retweeted
In our latest blog post Tineke Kleinhout-Vliek shows how decentralising clinical trials can be a form of social pharmaceutical innovation for rare disease treatment in Europe: socialpharmaceuticalinnovati…
conor douglas retweeted
A central challenge facing drugs for #rarediseases is the production of robust evidence given the inherently small patient populations within each disease, writes @cmwDouglas in International Experiences & Made-in-Canada “Social Pharmaceutical Innovations”
ow.ly/ew2U50MJiVE
conor douglas retweeted
Expensive Drugs for Rare Diseases in Canada: What Value & At What Cost?
Latest issue of #HealthcarePapers is out. @bobnakagawa @DeanRegier @joel_lexchin @reformulary @oncology_bg @kjmeetswrld @haronba @bubela_tania @cmwDouglas @picardonhealth @kellygrant1
ow.ly/vIEA50Mzi2X
conor douglas retweeted
Passionate about the intersection of science, society, and policy? Apply now for a fully funded PhD or MA in Science and Technology Studies. International and domestic students welcome.
Click here to learn more: buff.ly/3k2rfNg
#scicomm #sts #YorkU #scicom #ststwitter
conor douglas retweeted
Considering a career in academia? Applications are open for the largest and most diverse Science and Technology graduate program in Canada. Click here to learn how you could receive a fully funded MA or PhD degree: buff.ly/3k2rfNg #scicomm #sts #scicom #ststwitter
conor douglas retweeted
In our latest blog post, @cmwDouglas shares some of the recent real-world ways that our research team has been involved in contributing to advancing, supporting, and inspiring #SPIN initiatives.
Read the full post here:
socialpharmaceuticalinnovati…
#socialpharmaceuticalinnovation
conor douglas retweeted
Our latest blog post presents a summary on the book 'From Big Pharma to Commons' by Gaëlle Krikorian - providing insight into #socialinnovation in rare disease from a French perspective
Read more here: socialpharmaceuticalinnovati…
#raredisease #SPIN #socialpharmaceuticalinnovation
conor douglas retweeted
Chairs Douglas Mahoney, of @UCalgary & @cmwDouglas, of @YorkUniversity setting the stage for the plenary asking: What's the endgame for cancer #immunotherapy in Canada? #Summit4CI #CancerResearch
conor douglas retweeted
#Crowdfunding is an increasingly common means of raising money for patients with #rarediseases around the world to access #expensive treatments - some see this as an act of #solidarity, others would disagree.
Read more about this in our latest blog post:
socialpharmaceuticalinnovati…
conor douglas retweeted
If you're interested in doing an #MA or #PhD in social studies of #science, #technology & #innovation then check out our #STS graduate program - now recruiting for Sept 2023! Each place has funding & their are C$6k & C$8k entrance scholarships too!
yorku.ca/gradstudies/sts/
I'm excited to be presenting in the Health Symposium | 675: Social Pharmaceutical Innovation: Made-in-Canada solutions to address unmet medical needs for advanced therapeutics at CSPC 2022 sched.co/1A0Xf @sched
conor douglas retweeted
The first allogenic CAR-T treatment is one step closer to market authorisation, a development that is certain to have a substantial impact on treatment for patients with rare disease
Read more in our latest blog by @FaisalMohamedA
socialpharmaceuticalinnovati…
#raredisease #SPIN
conor douglas retweeted
In our latest blog post, our Brazilian researcher @Marina_Borba discusses the term 'scientific colonialism' as it relates to rare diseases and the Global South.
Read more about this interesting and eye-opening discussion here: socialpharmaceuticalinnovati…
#SPIN #RareDisease
conor douglas retweeted
As a result of the #COVID19 pandemic, many countries are developing improved #genomic surveillance programs. Many in the #raredisease field are wondering what effect this may have on patients who rely on genomic sequencing for diagnosis.
Read more here:
socialpharmaceuticalinnovati…
conor douglas retweeted
In our latest blog post, Gengler, a guest writer talks about how we frame the issue of #drugs for #rarediseases and how these framings may help us better understand the problem.
Read more:
socialpharmaceuticalinnovati…
#socialpharmaceuticalinnovation #SPIN #Lenalidomide #Revlimid
conor douglas retweeted
The Research Seminar Series in Science, Technology and Society will return for the 2022-23 academic year! Click to see a summary of seminars on a wide range of STS-related topics scheduled for this Fall! https://teapawt.net/t.co/ZTx4rGFUxS | @YorkUScience @CDNJobar @GanaeleLanglois
conor douglas retweeted
In our latest blog post, our research team identifies proof that alternative forms of research and development are possible by reflecting on the treatment for SPG50 which was found in Canada
Read more
socialpharmaceuticalinnovati…
#SPIN #socialpharmaceuticalinnovation #raredisease















